CD8A and neoplasm: Further, the current study, OVs combined with immune checkpoint inhibitors and autophagy modulators markedly improved CD8 + T-cell responses and tumor regression in solid tumors and pointed to the role of OVs in priming the tumor microenvironment for immune-mediated attack.